Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.


AI/ML

Biotechnology

Delivery

Mana.bio

Yogev Debbi

Luciana Pillemer Kanner

Alex Lagadinos

Kira Radinsky

Roy Nevo

Amit Benazraf

Omri Amirav-Drory

The Scientific Team at Mana.bio is responsible for advancing the development of Lipid Nanoparticle (LNP) technology for oligonucleotide therapies. This includes conducting cutting-edge research, optimizing formulations, and ensuring the scientific rigor and innovation required to propel mRNA-based therapeutics, vaccines, and gene therapies from concept to clinical application.

Scientific Team

This department focuses on conducting experiments and analyses in a laboratory setting.

Laboratory Services

The Data Acquisition Team at Mana.bio is responsible for gathering, curating, and maintaining high-quality datasets crucial for the development of lipid nanoparticles (LNPs) used in oligonucleotide therapies. This team ensures the integrity and accuracy of data, enabling advanced AI-driven modeling and optimization for mRNA-based therapeutics, vaccines, and gene therapies.

Data Acquisition Team

The Leadership Team at Mana.bio is tasked with setting the strategic vision and direction of the company, driving innovation in AI-based drug delivery solutions, and overseeing the development of Lipid Nanoparticle technologies. They collaborate closely to ensure the alignment of business goals with scientific research, advocate for the company's mission in the biotech community, and secure partnerships and funding essential for advancing oligonucleotide therapies.

Mana.bio

Org chart

Board & advisors

Teams

Scientific Team

Laboratory Services

Data Acquisition Team

Leadership Team

Offices

Mana.bio

Org chart

Board & advisors

Teams

Scientific Team

Laboratory Services

Data Acquisition Team

Leadership Team

Offices

Related companies